Venezuela exposure profile · ABBV · Health Care

AbbVie (ABBV): Venezuela Exposure Check

Independent audit of AbbVie's exposure to Venezuela — OFAC SDN matches, SEC filings, and Caracas Research news corpus.

Indirect exposure

AbbVie has disclosed Venezuela-related items in 2 recent SEC filings.

AbbVie has filed 2 recent SEC documents (10-K) containing Venezuela / PdVSA / CITGO references. This is the company's own disclosure and is the strongest evidence of material exposure short of an OFAC designation. See the SEC filings section below for excerpts.

Ticker
ABBV
S&P 500 sector
Health Care
Headquarters
North Chicago, Illinois
OFAC matches
0
EDGAR filings
2
Last refreshed
2026-04-19

OFAC Venezuela SDN matches

No entry on the OFAC Venezuela SDN list contains AbbVie as of the most recent OFAC scrape. Always re-verify with OFAC Sanctions Search before transacting.

SEC filings disclosing Venezuela items

AbbVie has filed 2 recent SEC documents containing references to Venezuela, PdVSA, CITGO or related terms. These are the company's own disclosures.

SEC EDGAR · accession 0001551152-26-000008
SEC EDGAR · accession 0001551152-25-000020

Federal Register & news corpus mentions

No Federal Register notice or analyzed news article in our corpus references AbbVie in a Venezuela context. Search the live sanctions tracker or the daily briefing index for ad-hoc context.
Methodology. This page combines four signals: (1) a hand-curated map of S&P 500 Venezuela exposure maintained by Caracas Research analysts; (2) fuzzy substring matching against every Venezuela-program OFAC SDN designation (refreshed twice daily); (3) the SEC EDGAR full-text search across the company's 10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months; (4) a scan of our own analyzed-news corpus and US Federal Register notices. Last refreshed 2026-04-19. This is not legal or compliance advice; always verify with primary sources and qualified sanctions counsel before transacting.

Useful tools